ACR Alpine Capital Research recently lifted its ownership of Elevance Health (ELV) by 25% in the third quarter, after the insurer raised its 2026 adjusted earnings outlook to at least $29 per share.
That earnings upgrade and ACR’s larger position come after a solid run for Elevance Health, with the share price returning 7.85% over the past 90 days and 21.24% year to date. The 1 year total shareholder return of 33.69% points to momentum that has been building rather than fading.
Scan for other insurance and healthcare stocks with similar earnings power and valuation traits using our curated list of 32 high quality undervalued stocks.
After a sharp run and a raised earnings bar, Elevance Health still trades below analyst targets and some estimates of fair value. Is the gap a genuine margin of safety, or a warning the market is not ignoring?
Most Popular Narrative: 9.5% Undervalued
Against a last close of $429.48, the analyst consensus Narrative on Simply Wall St points to a fair value of $474.57 for Elevance Health, framing the current discount through detailed revenue and earnings forecasts and an explicit 7.28% discount rate.
Ongoing deployment of Elevance Health’s AI, analytics and digital platforms such as HealthOS and Sydney Health, including automated prior authorization and earlier visibility into medical cost trends, is expected to tighten medical cost management and support more stable net margins and earnings over time.
See why 120 investors see Elevance Health as 10% undervalued.
Result: Fair Value of $474.57 (UNDERVALUED)
Still, the Elevance Health story can be knocked off course if medical cost trends in ACA and Medicaid stay elevated, or if membership erosion continues, pressuring margins and earnings quality.
Find out about the key risks to this Elevance Health narrative.
Next Steps
Sentiment around Elevance Health is mixed, with solid fundamentals on one side and flagged issues on the other. Move quickly, test the numbers yourself, then weigh both sides of the story through the 4 key rewards and 1 important warning sign
Looking for more investment ideas beyond Elevance Health?
If Elevance Health has your attention, do not stop there. Cast a wider net now so you are not relying on a single story.
- Target reliable income streams by reviewing 6 dividend fortresses that could help anchor your portfolio with consistent cash payouts.
- Hunt for resilient businesses by scanning the 30 resilient stocks with low risk scores that keep risk scores in check while still offering room for upside.
- Spot future leaders early by combing through the 19 high quality undiscovered gems before the wider market pays attention.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com